Paul Coley
Pulmonary Disease · Jacksonville, FLNPI 1962468892
Payments from drug & device makers
Across 129 payments — averaging $1632.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$208K
- GSK$716
- AstraZeneca$347
- Grifols USA, LLC$225
- Philips North America LLC$140
- Sunovion Pharmaceuticals Inc.$133
- plus $587 from 17 others
What the payments were for
- Food & beverage$2,148100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 4 | $208,495 |
| GSK | 43 | $716 |
| AstraZeneca | 16 | $347 |
| Grifols USA, LLC | 11 | $225 |
| Philips North America LLC | 12 | $140 |
| Sunovion Pharmaceuticals Inc. | 9 | $133 |
| Mylan Specialty L.p. | 3 | $71 |
| Boehringer Ingelheim | 4 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| AbbVie | 4 | $52 |
| Merck | 3 | $46 |
| Electromed, Inc. | 3 | $44 |
| Mallinckrodt Enterprises LLC | 2 | $37 |
| Genentech USA, Inc. | 2 | $35 |
| Insmed, Inc. | 2 | $34 |
| Circassia Inc. | 2 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Optinose US, Inc. | 1 | $19 |
| Novartis | 1 | $17 |
| Portola Pharmaceuticals, LLC | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
| Pfizer | 1 | $11 |
| Bayer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$125
- FASENRA$103
How this compares
$210,643 in reported general payments places this provider in the 90th percentile of 953 pulmonary disease providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azithromycin | 13 | $71 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Jacksonville
- Charles BurgerJacksonville$5.6M
- Abubakr BajwaJacksonville$1.4M
- Jennifer FultonJacksonville$791K
- Sebastian Fernandez-BussyJacksonville$559K
- Remzi BagJacksonville$556K
- Jose Soto SotoJacksonville$549K
- Augustine LeeJacksonville$533K
- Jorge MalleaJacksonville$478K
- James KrainsonMiami$11.7M
- Jose DiazLeesburg$11.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.